NeuroICH

Neurocareai Inc.'s NeuroICH is an AI-powered radiological computer-aided triage and notification tool designed to rapidly identify suspected intracranial hemorrhage (ICH) from non-contrast head CT images. It employs a deep learning algorithm to analyze images in parallel with standard interpretation, demonstrating high sensitivity and specificity in retrospective studies, aiming to expedite specialist involvement through quick notifications.

Neurocareai Inc.'s NeuroICH is a software-based radiological computer-aided triage and notification tool, leveraging an artificial intelligence algorithm to analyze non-contrast head CT images for findings suggestive of intracranial hemorrhage (ICH). It functions in parallel with standard image interpretation to identify suspected ICH cases and automatically sends notifications, including non-diagnostic preview images, to appropriate specialists. The device is intended solely for informational purposes, aiding in streamlined communication and earlier specialist involvement, rather than serving as a diagnostic tool, with final diagnostic and care decisions remaining the responsibility of trained clinicians based on high-quality diagnostic images. The NeuroICH device utilizes deep learning AI algorithms, similar to the legally marketed predicate device Viz ICH, and offers mobile application interfaces for notifications without altering original medical images or disrupting standard hospital workflows. Performance data from a retrospective study demonstrated its effectiveness, achieving a sensitivity of 94.81% and a specificity of 92.53% in identifying ICH cases. Furthermore, the average time to notification was exceptionally fast at 0.37 0.20 minutes, significantly accelerating specialist awareness compared to traditional processes and underscoring its potential to enhance the timely identification and management of critical patients.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the NeuroICH device's AI algorithm perform in detecting subtle or atypical intracranial hemorrhages, and what are its specific limitations in such scenarios?; What real-world impact does the rapid notification feature have on patient outcomes, particularly regarding time to intervention or neurological recovery, beyond the observed time savings?; Are there specific patient demographics or imaging characteristics (e.g., artifacts, scan quality) that might affect the NeuroICH device's reported sensitivity and specificity?; What mechanisms are in place for the NeuroICH device to continuously learn and update its AI algorithm, ensuring sustained or improved performance over time?; How does the integration of NeuroICH affect the cognitive load or diagnostic responsibilities of clinicians, given its non-diagnostic informational purpose?